Download Unicorn Signals App

Powered By EquityPandit
 Signals, Powered By  EquityPandit
BUSINESS

Blackstone in Talks with Advent International to Acquire Controlling Stake in Suven Pharma

Blackstone and Advent International are in separate talks with the promoters of Suven Pharmaceuticals Ltd to buy a controlling stake.

On November 4, Livemint reported that private equity investors Blackstone and Advent International are in separate talks to buy a controlling stake in Suven Pharmaceuticals.


Moneycontrol first reported on September 7 that the promoters of Suven Pharma have been evaluating options to sell a stake in the company and had hired an investment bank as an advisor. The promoters own 60% of Suven Pharma with a market capitalisation of Rs 6,378 crore.


The sale of at least half the stake would take the deal size to over Rs 3,000 crore, followed by a 26% public offering, which, if successful, could cost the final buyer an additional Rs 1,600-1,700 crore, the report said.


Moneycontrol had earlier reported that the promoter group was exploring its sales plan ahead of the launch of Suven Pharmaceuticals on February 12, 2020.

Get Daily Prediction & Stocks Tips On Your Mobile